ELEVATED LEVELS OF N-TERMINAL BRAIN NATRIURETIC PEPTIDE AND TROPONIN T CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS

ELEVATED LEVELS OF N-TERMINAL BRAIN NATRIURETIC PEPTIDE AND TROPONIN T CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS

Bibliographic Details
Main Authors:	Landray, M, Ayrton, P, Blackwell, L, Nuttall, S, Nair, D, Townend, J, Baigent, C, Wheeler, D
Format:	Journal article
Published:	2005

Similar Items

ELEVATED LEVELS OF ASYMMETRIC DIMETHYLARGININE (ADMA) AND SYMMETRIC DIMETHYLARGININE (SDMA) CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS
by: Landray, M, et al.
Published: (2005)

SERUM LIPIDS DO NOT PREDICT CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS
by: Landray, M, et al.
Published: (2005)

Kidney Function Specific Reference Limits for N-terminal Pro Brain Natriuretic Peptide and High Sensitivity Troponin T: The Systolic Blood Pressure Intervention Trial
by: Nisha Bansal, MD, et al.
Published: (2022-09-01)

Two-year survival among patients with chronic-kidney disease not on dialysis: The chronic renal impairment in Birmingham (CRIB) study.
by: Nuttall, S, et al.
Published: (2003)

Plasma Levels of Brain Natriuretic Peptides and Cardiac Troponin in Hemodialysis Patients
by: Halima Resić, et al.
Published: (2009-05-01)

DIAGNOSTIC AND PROGNOSTIC VALUES OF B-TYPE NATRIURETIC PEPTIDES AND N-TERMINAL FRAGMENT BRAIN NATRIURETIC PEPTIDES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE
by: V. N. Vasilkova, et al.
Published: (2018-02-01)

Cardiac Troponin I but Not N-Terminal Pro-B-Type Natriuretic Peptide Predicts Outcomes in Cardiogenic Shock
by: Tobias Schupp, et al.
Published: (2023-08-01)

Clinical value of natriuretic peptides in chronic kidney disease
by: Carla Santos-Araújo, et al.
Published: (2015-05-01)

Clinical value of natriuretic peptides in chronic kidney disease
by: Carla Santos-Araújo, et al.
Published: (2015-05-01)

Urinary N-Terminal Pro-Brain Natriuretic Peptide Predicts Acute Kidney Injury and Severe Disease in COVID-19
by: Manuel Julian Vogel, et al.
Published: (2023-06-01)

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity
by: F. Fernandes, et al.
Published: (2007-02-01)

Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
by: Paolo Morfino, et al.
Published: (2022-08-01)

N‐terminal brain natriuretic peptide, cardiac troponin‐I, and point‐of‐care ultrasound in dogs with cardiac and noncardiac causes of nonhemorrhagic ascites
by: Alice G. N. Morey, et al.
Published: (2023-05-01)

Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients
by: Chen JR, et al.
Published: (2018-12-01)

Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High‐Sensitivity Troponin T, and N‐Terminal Pro–Brain‐Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction
by: Benjamin Lidgard, et al.
Published: (2022-06-01)

Brain natriuretic peptide and cardiac troponin I for prediction of the prognosis in cancer patients with sepsis
by: Yong Yang, et al.
Published: (2021-05-01)

High sensitivity Troponins In Patients with elevated prohormone of beta natriuretic peptide and acute heart failure (HIGH TRIP Trial)
by: Wesam A. Alhejily
Published: (2022-02-01)

Routinely measured cardiac troponin I and N‐terminal pro‐B‐type natriuretic peptide as predictors of mortality in haemodialysis patients
by: Masahiro Eriguchi, et al.
Published: (2022-04-01)

Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.
by: Landray, M, et al.
Published: (2004)

Correlation between Troponin I, N-terminal pro–B-type natriuretic peptide, and left ventricular ejection fraction in acute coronary syndrome patients with mortality
by: Darshit Pansuriya, et al.
Published: (2021-01-01)

Hospitalization and medical cost of patients with elevated serum N-terminal pro-brain natriuretic peptide levels.
by: Toshiro Kitagawa, et al.
Published: (2018-01-01)

Utility of cardiac biomarkers in sports medicine: Focusing on troponin, natriuretic peptides, and hypoxanthine
by: Anirban Mahanty, et al.
Published: (2020-06-01)

Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study
by: Jun Xiao, et al.
Published: (2021-03-01)

PO-04 CORRELATIONS BETWEEN ARTERIAL STIFFNESS/CENTRAL HEMODYNAMICS AND SERUM CARDIAC TROPONIN T AND NATRIURETIC PEPTIDE LEVELS
by: Hirofumi Tomiyama, et al.
Published: (2014-11-01)

Prediction of Heart Function and Volume Status in End-Stage Kidney Disease Patients through N-Terminal Pro-Brain Natriuretic Peptide
by: Kyung Ho Lee, et al.
Published: (2022-07-01)

Value of N-terminal pro brain natriuretic peptide in predicting acute kidney injury in patients with acute decompensated chronic heart failure
by: M V Menzorov, et al.
Published: (2017-03-01)

Associations of High‐Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT
by: Simon B. Ascher, et al.
Published: (2022-03-01)

Which cardiovascular risk factors matter in chronic kidney disease?
by: Baigent, C, et al.
Published: (2007)

Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
by: Changlin Zhang, et al.
Published: (2016-01-01)

Walking Ability and Brain Natriuretic Peptide Are Highly Predictive of Kidney Transplant Waiting List Removal
by: Daniel A. Katz, MD, et al.
Published: (2023-06-01)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
by: Pang-Yen Liu, et al.
Published: (2023-08-01)

Evaluation of Serum Levels of N-terminal Pro Brain Natriuretic Peptide and Atrial Natriuretic Peptide in Neonates with Respiratory Distress
by: Noor Mohammad Noori, et al.
Published: (2016-06-01)

Serum brain natriuretic peptide (BNP) and N-terminal brain natriuretic peptide (NT-proBNP) in heart valve disease
by: J.A. Moolman, et al.
Published: (2017-04-01)

Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.
by: Zehnder, D, et al.
Published: (2007)

HIIT effects on Troponin I and B-type natriuretic peptide in rats undergone radiotherapy
by: Behzad Aria, et al.
Published: (2022-10-01)

Assessment of predictive value of natriuretic peptides and troponin I in clinical outcomes of severe sepsis
by: Mei Wu, et al.
Published: (2022-11-01)

Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
by: Lena Hinrichs, et al.
Published: (2020-05-01)

The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease.
by: Yi-Chun Tsai, et al.
Published: (2018-01-01)

Risk Stratification of Pulmonary Thromboembolism using Brain Natriuretic Peptide and Troponin I; a Brief Report
by: Mohsen Ebrahimi, et al.
Published: (2022-01-01)

Factors associated with increased levels of brain natriuretic peptide and cardiac troponin I during the peripartum period.
by: Yuki Kimura, et al.
Published: (2019-01-01)